Every gap has the same shape: two things the AHA already owns, or already stands beside, that never touch. The space between them is currently filled by voices paid in engagement, by voices paid in attention, or by nothing at all. Each bridge is a connection job — in every case the expensive part already exists. The gaps are openings, and each one shows a possibility the institution can act on now.
Each row holds two things that should connect and don’t: what the AHA already owns on the left, what the consumer world runs on the right, and the hatched band between them — the gap, filled today by engagement, by attention, or by no one. The green bar is the bridge that closes it. Tap any row for the full case below.
On one side sit the AI imaging tools that now read coronary calcium off routine mammograms, already reporting findings to women and their doctors. On the other: the AHA’s guideline machinery, which can say what a calcium number means only after the evidence accumulates. Nancy and Susie have carried this one for months — another organization is already moving on it, and as Nancy put it, “the doctors don’t know” how much calcium should worry anyone.
The space between is empty because the guideline voice is the only voice available, and a guideline takes years while the reports arrive this week. The caution holding the silence in place is the right instinct — “we don’t speak until we know” is why the brand is trusted — so the answer has to protect that instinct rather than override it.
The bridge: an interim, confidence-graded AHA read on what calcium findings from breast imaging do and do not mean, issued now and revised on a stated schedule as evidence accrues.
If the bridge goes up, the first thing to close is the read itself — the inaugural piece of confidence-colored guidance, shipped this quarter with its grade visible, the way one planning member sketched it on the call: lime green reads differently from red, and saying “here is how sure we are” protects the trust instead of spending it.
On one side: the monitoring reports Greg Donaldson’s desk produces every morning — a single day’s report logs 70,000 engagements with heart-health misinformation. On the other: the Diligent board portal, where the board reads quantified risk on everything else it governs.
Those two never meet. The number arrives daily, staff absorb it, and it stops there. The point was made directly on the call: most board colleagues don’t understand the extent of what the staff sees every day, and the board is sitting in isolation from it. So the board is asked to fund a response to a threat it has never seen on paper — a hard ask for any fiduciary, and the reason the urgency feels abstract in the boardroom while it feels concrete at the monitoring desk.
The space is empty for a simple reason: nobody’s job is to carry the number upstairs.
The bridge: a standing exposure line in the board book that converts the daily monitoring feed into a fiduciary risk item, reviewed like any other.
The first close is formatting work — one month of existing monitoring reports rolled into a single line for next quarter’s book. The harder questions (what scale, whose number, what actions trigger at which levels) belong to the board, and the line is what puts them on the table.
On one side: everything upstream of a guideline — the hypotheses, the active studies, the 70-percent findings the evidence machine produces continuously. On the other: the daily feed of live consumer questions about peptides, raw milk, screen time, protein. Even granting the diagnosis that the guideline voice has been the institution’s only public voice, this gap sits upstream of any voice: the pipeline itself is the institution’s largest idle content asset, and current practice releases none of it until it reaches guideline grade.
The space is empty because studies have been treated as inputs to a future statement rather than statements in their own right. But a study’s existence is itself a signal. “We are studying screen time and heart rate, and here is why” tells a parent to pay attention years before a guideline could say anything — the concern is the message, delivered at the moment it is useful.
The bridge: run studies-in-progress through the graded voice as a standing stream — here is what we are studying, here is the hypothesis, here is where the evidence leans so far.
The first close is a studying-out-loud pilot: pick a handful of active studies, publish the what and the why with confidence grades attached, and let the pipeline speak while it works.
On one side: the venues where heart-health questions actually get asked — social feeds and AI chat answers. The voices there run on two currencies: influencers are paid in engagement, and chat is paid in attention, the sycophantic pull that keeps a user coming back by telling her what she wants to hear. On the other side: the one major heart-health voice free of both currencies, fielding no presence in the venues where they trade.
The space is empty because the AHA’s freedom from those incentives — the exact thing that makes its answer worth more — has never been packaged as a credential a consumer can see in the moment she is asking. Absence reads as silence, and the incentive-paid voices fill it.
The bridge: a human-gated AHA presence inside the third-party venues themselves — the chat answer, the comment thread, the feed — wearing its incentive-freedom openly: no product to sell, no engagement to farm, every statement reviewed by a person.
The first close is a working pilot of this voice: an AHA presence answering the relevant posts and chat answers with humans in the loop, built from the fact queue the existing monitoring reports already feed. The two planning calls already contain enough material to define it.
On one side: a peer’s playbook. The planning group pointed to the British Heart Foundation’s network of street-level walk-in locations — heart health encountered in the course of an ordinary day. On the other: the AHA’s verified content, already built and already paid for, waiting behind annual events and the website while the surfaces Americans actually stand at — the gym door, the hospital lobby, the wearable alert, the chatbot answer — go unstaffed.
The space is empty because distribution has been treated as campaign work, and campaigns visit a surface once a year. The optimistic read from the huddle holds: the hard part is the concrete knowledge and content, the AHA has it, and that is where the money has gone for a century. What remains is skinning it onto everyday surfaces.
The bridge: treat distribution as a packaging task — existing verified content, re-skinned per surface, no new science required.
The first close is the wearable wedge. Whoop and Apple put heart data on millions of wrists; the interpretation behind the alert is the open seat, and the AHA’s name is the one an alert can borrow. We would start there: verified AHA interpretation behind the wearable alert, the first of two surfaces to staff for the next twelve months.
On one side: the influencer doctor the AHA most often amplifies — he tends to agree with the guidelines, so leaning on him felt safe. On the other: the board’s own bench. Dr. Jen Ashton — double board certified, a former network chief medical correspondent, a member of the AHA board — reviewed his content and brought back six examples where he is completely wrong. Her worry was the brand attaching itself to him, because the errors travel with the endorsement.
That puts the current arrangement past absence into liability: the brand’s credibility rides with a voice the institution can neither correct nor retract. Silence costs reach; endorsement of an uncontrolled voice spends trust directly.
The space is empty because the influencer format has been treated as something to borrow. Nobody has been developed in-house for it — yet the people with the credentials, the fluency, and the camera experience are already in the room, on the board itself.
The bridge: replace amplification with ownership — develop on-camera faces for the influencer format from the AHA’s own experts, and let venue presence ride with the engagement-economy move.
The first close is one face and one format: screen-test the board’s own communicators, build a single repeatable format around the strongest, and let the borrowed amplification wind down as the owned voice stands up.
Sources: the June 2026 planning-call transcript and our follow-up huddle, prior AHA reports of record (the February 2026 gap analysis), and the engagement’s verified statistics ledger. Every claim above traces to one of them.